Attovia Therapeutics | $105,000,000 | (May 14, 2024)
Glacis Labs | $2,000,000 | (May 14, 2024)
GigPig | $1,631,441 | (May 14, 2024)
Certified by Founder
Lodge
Antiverse
start up
United Kingdom
- Cardiff, Wales
- 03/03/2023
- Unknown
- $3,000,000
Antiverse is building a world-first computational antibody drug discovery platform. We combine in-house lab expertise with state of the art machine learning to predict antibody-antigen binding and provide antibody drug candidates in weeks.
- Industry Pharmaceutical Manufacturing
- Website https://www.antiverse.io/
- LinkedIn https://www.linkedin.com/company/antiverse/
Related People
Murat TunaboyluFounder
United Kingdom -
Cardiff, Wales
CEO of Antiverse, background in software engineering and bioinformatics. Mid-career developed high-frequency trading systems. After switching to biotech, built cell imaging software and lab robots to accelerate cancer research and automated Thermo Fisher Scientific’s gene synthesis workflows. Co-founded consultancy and biotech companies Svarlight and Antiverse.
Currently focusing on to realise Antiverse’s mission: engineering the future of drug discovery.
CereVasc | $70,000,000 | (May 14, 2024)
Active Surfaces | $5,600,000 | (May 14, 2024)
May Health | $25,000,000 | (May 14, 2024)
ByHeart | $95,000,000 | (May 14, 2024)
tiney | $9,034,812 | (May 14, 2024)
Hexis | $2,009,680 | (May 14, 2024)
Nivoda | $30,000,000 | (May 14, 2024)
Switchboard Health | $6,500,000 | (May 14, 2024)
Aardvark Therapeutics | $85,000,000 | (May 10, 2024)